Future Oncology Journal Issues Research Articles in Part 1 of July 2020 Edition
June 25, 2020
June 25, 2020
LONDON, England, June 25 -- Future Oncology, a journal that says it provides a forum for a new era of cancer care, published research articles, including the following topics, in Part 1 of its July 2020 edition:
* Selinexor: a first-in-class SINE compound for treatment of relapsed refractory multiple myeloma
Research Article:
* Risk factors for developing cardiac toxicities in cancer patients treated with panitumumab combination therapy
Review . . .
* Selinexor: a first-in-class SINE compound for treatment of relapsed refractory multiple myeloma
Research Article:
* Risk factors for developing cardiac toxicities in cancer patients treated with panitumumab combination therapy
Review . . .